← TrialMatch
HomeTrials

CHOLE-POSSUM PRO Validation for Prediction of Mortality After Cholecystectomy for Acute Ca

CHOLE-POSSUM PRO is a prospective multicenter observational study on patients with ACC candidate to EC. The rationale of the study is to validate the CHOLE-POSSUM PRO SCORE for 30-day mortality in this population.

Condition(s)Acute Calculous Cholecystitis Candidate to Early Cholecystectomy
StatusRecruiting
Study typeObservational
SummaryCHOLE-POSSUM PRO is a prospective multicenter observational study on patients with ACC candidate to EC. The rationale of the study is to validate the CHOLE-POSSUM PRO SCORE for 30-day mortality in this population.
Who can participateInclusion Criteria: * have a diagnosis of ACC as defined by TG18 criteria * be ACC candidate to EC during the index admission\* (\* All the patients treated with initial open cholecystectomy, those who undergo ELC, those with conversion from laparoscopic to open cholecystectomy or those who undergo bail out procedures (e.g. subtotal cholecystectomy) will be included.) * be ≥ 18 years old * be stratified for the risk of CBDS according to the Israelian Score (29), and, in case of confirmation of CBDS receive pre-operative ERCP * provide signed and dated informed consent form * willing to comply with all study procedures and be available for the duration of the study. Exclusion Criteria: * pregnancy or lactation * acute cholecystitis not related to a gallstone etiology * onset of symptoms \>1
Ages18 Years
SexAll
Lead sponsorFondazione IRCCS Policlinico San Matteo di Pavia
LocationsPavia, Pavia, Italy
Start date2024-03-01
NCT IDNCT06908980
Official listinghttps://clinicaltrials.gov/study/NCT06908980

🔍 Search all trials →